We are live on
!
Find out more
PCM
Peregrine Capital Management Portfolio holdings
AUM
$3.08B
1-Year Est. Return
29.51%
This Fund
S&P 500
This Quarter
Est. Return
+8.84%
1 Year Est. Return
+29.51%
3 Year Est. Return
+95.04%
5 Year Est. Return
+107.83%
10 Year Est. Return
+715.34%
AUM
$3.19B
AUM Growth
+$101M
(+3.3%)
Cap. Flow
-$58.6M
Cap. Flow
% of AUM
-1.84%
Top 10 Holdings %
Top 10 Hldgs %
16.65%
Holding
340
New
17
Increased
56
Reduced
185
Closed
23
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Snowflake
SNOW
|
+$27.5M |
| 2 |
Uber
UBER
|
+$20.6M |
| 3 |
GDEN
Golden Entertainment
GDEN
|
+$10.5M |
| 4 |
THS
Treehouse Foods
THS
|
+$10.1M |
| 5 |
HBI
Hanesbrands
HBI
|
+$9.58M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ABMD
Abiomed Inc
ABMD
|
+$29.4M |
| 2 |
AVLR
Avalara, Inc.
AVLR
|
+$29.4M |
| 3 |
EVOP
EVO Payments, Inc. Class A Common Stock
EVOP
|
+$14.3M |
| 4 |
Meta Platforms (Facebook)
META
|
+$12.9M |
| 5 |
SYNH
Syneos Health, Inc. Class A Common Stock
SYNH
|
+$12.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.39% |
| 2 | Healthcare | 18.05% |
| 3 | Financials | 16.4% |
| 4 | Consumer Discretionary | 13.46% |
| 5 | Industrials | 11.67% |
Similar funds
CAM
VBA
MRCP
ECP
HCM
DCM
TCG
CLG
Peregrine Capital Management's Q4 2022 Portfolio in Review
As of Q4 2022, Peregrine Capital Management held 340 positions worth $3.19B, up 3.3% from $3.09B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Peregrine Capital Management's Q4 2022 filing shows 17 new, 56 increased, 185 reduced and 23 closed positions. Its largest new stake was Snowflake: 180,455 shares worth $25.9M. The largest sale was Abiomed Inc, an estimated $29.4M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
- Peregrine Capital Management's largest Q4 2022 buy was Snowflake: 180,455 shares worth $25.9M.
- Peregrine Capital Management added most to CrowdStrike in Q4 2022, an estimated $7.47M increase.
- Peregrine Capital Management's biggest Q4 2022 reduction was EVO Payments, Inc. Class A Common Stock, cutting an estimated $14.3M.
- Peregrine Capital Management fully exited Abiomed Inc in Q4 2022, selling an estimated $29.4M.
- Peregrine Capital Management's ten largest holdings make up 17% of its $3.19B portfolio in Q4 2022.
- Peregrine Capital Management opened 17 new positions and closed 23 in Q4 2022.
- Peregrine Capital Management's portfolio value rose 3.3% quarter-over-quarter to $3.19B.
Based on Peregrine Capital Management's 13F filing for Q4 2022, filed 10 Jan 2023.